David A. Matzilevich, MD is a leading stem cell researcher where his work focuses on stem cell based therapeutic approaches. Prior to dedicating himself to stem cell research, Dr. Matzilevich was a faculty member at McLean Hospital and Harvard Medical School. His work there involved identification of molecular endophrenotypes and suseptibility genes involved in the pathogensis of Schizophrenia and Bipolar Disorder.

Dr. Matzilevich received his MD, PhD from the Imperial College of Science, Technology and Medicine in London, UK. Following his studies in London, Dr. Matzilevich received a fellowship in the Department of Pathology at Tufts Medical School in Boston and went on to the University of Texas Medical Center at Houston in the Department of Neuroscience and the Keck Center for Neurology and Neurosurgery where he worked on the use of adult stem cells for the treatment of neurological disorders. Dr. Matzilevich is currently involved in several clinical trials using adult stem cells for treating neurological disorders.

Dr. Matzilevich lectures extensively on stem cells, holds several patents and has published over 30 peer reviewed articles and papers. Dr. Matzilevich appears frequently on TV, radio, industry and scientific journals as well as mainstream print media as an acknowledged stem cell expert.